Hasegawa and colleagues delivered recombinant VEGF-C via an osmotic pump implanted into mice with unilateral ureteral obstruction, a model of renal fibrosis, and reported a significant reduction in renal interstitial fibrosis and inflammation compared to controls [27]. Here, VEGFC is linked to Ureteral obstruction.